Geographic Atrophy
Showing 1 - 25 of 1,653
Geographic Atrophy and Their Patient Journey in United States
Not yet recruiting
- Geographic Atrophy
- (no location specified)
May 26, 2023
Macular Degeneration, Age Related, Geographic Atrophy Trial in Madison (Spectralis FAF imaging, Optos imaging, Zeiss Clarus 700
Not yet recruiting
- Macular Degeneration, Age Related
- Geographic Atrophy
- Spectralis FAF imaging
- +2 more
-
Madison, WisconsinUniversity of Wisconsin
Jul 18, 2023
Geographic Atrophy Trial in Bellaire, Dallas (OCU410)
Recruiting
- Geographic Atrophy
- OCU410
-
Bellaire, Texas
- +1 more
Aug 25, 2023
Optical Coherence Tomography and Microperimetry Biomarker
Active, not recruiting
- Age-Related Macular Degeneration
- +2 more
- Natural history study
-
Basel, Basel-Stadt, SwitzerlandUniversity Hospital Basel
Jul 19, 2023
Geographic Atrophy Trial (BI 771716)
Not yet recruiting
- Geographic Atrophy
- BI 771716
- (no location specified)
Aug 29, 2023
Geographic Atrophy of the Macula, Macular Degeneration Trial in United States (AVD-104, Sham injection)
Not yet recruiting
- Geographic Atrophy of the Macula
- Macular Degeneration
- AVD-104
- Sham injection
-
Saint Petersburg, Florida
- +4 more
Apr 20, 2023
Geographic Atrophy Trial in Cincinnati (OpRegen)
Recruiting
- Geographic Atrophy
- OpRegen
-
Cincinnati, OhioCincinnati Eye Institute
Jan 12, 2023
Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)
Recruiting
- Geographic Atrophy
- Macular Degeneration
- JNJ-81201887
- +4 more
-
Phoenix, Arizona
- +3 more
Mar 31, 2023
Age-Related Macular Degeneration Trial (Active Comparator CT1812, Placebo Comparator)
Not yet recruiting
- Age-Related Macular Degeneration
- Active Comparator CT1812
- Placebo Comparator
- (no location specified)
Jun 5, 2023
Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)
Recruiting
- Age-Related Macular Degeneration
- iPSC-derived RPE/PLGA transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Geographic Atrophy Insights (i-GAIN) Natural History Study
Recruiting
- Dry Age-related Macular Degeneration
- +6 more
-
Belfast, United Kingdom
- +11 more
Mar 22, 2023
Age-Related Macular Degeneration Trial run by the NEI (Minocycline)
Active, not recruiting
- Age-Related Macular Degeneration
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 22, 2022
Age-related Macular Degeneration (AMD) Trial in Créteil (Dimethyl Fumarate (TECFIDERA™), No active : no treatment)
Recruiting
- Age-related Macular Degeneration (AMD)
- Dimethyl Fumarate (TECFIDERA™)
- No active : no treatment
-
Créteil, Val De Marne, FranceCentre intercommunal de Créteil
Aug 2, 2022
Geographic Atrophy Associated With Age-Related Macular
Recruiting
- Age-Related Macular Degeneration
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 21, 2022
Geographic Atrophy, Age-Related Macular Degeneration Trial in Barcelona (postbiotics (IGENH35.3A), vitamins (AREDS formulation
Active, not recruiting
- Geographic Atrophy
- Age-Related Macular Degeneration
- postbiotics (IGENH35.3A)
- vitamins (AREDS formulation and recommended daily dose)
-
Barcelona, SpainInstitut de la Màcula
Jun 18, 2022
Non-Exudative (Dry) Age-related Macular Degeneration (dAMD) Trial (EG-301, AREDS2 supplements)
Not yet recruiting
- Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
- EG-301
- AREDS2 supplements
- (no location specified)
Jul 27, 2022
Age-Related Macular Degeneration, Geographic Atrophy Trial in Holon (smaller incision, new generation implantable miniature
Not yet recruiting
- Age-Related Macular Degeneration
- Geographic Atrophy
- smaller incision, new generation implantable miniature telescope (SING-IMT)
-
Holon, Tel Aviv, IsraelWolfson Medical Center
Jul 3, 2023
Geographic Atrophy, Age Related Macular Degeneration, AMD Trial in Somerville (ALK-001 oral capsule, Placebo oral capsule)
Active, not recruiting
- Geographic Atrophy
- +3 more
- ALK-001 oral capsule
- Placebo oral capsule
-
Somerville, MassachusettsCoordinating Center
Feb 15, 2022
Geographic Atrophy, Macular Degeneration Trial in Dallas (Avacincaptad pegol 2 mg intravitreal injection)
Not yet recruiting
- Geographic Atrophy
- Macular Degeneration
- Avacincaptad pegol 2 mg intravitreal injection
-
Dallas, TexasRetina Foundation of the Southwest
Sep 7, 2022
Age-related Macular Degeneration, Geographic Atrophy Trial (VOY-101)
Recruiting
- Age-related Macular Degeneration
- Geographic Atrophy
- VOY-101
-
Bellaire, TexasRetina Consultants of Texas
Nov 17, 2022
ORACLE: A Long-term Follow-up Study to Evaluate Safety and
Enrolling by invitation
- Age Related Macular Degeneration (AMD)
- GT005
-
Reno, NevadaSierra Eye Associates
Aug 9, 2022
Age-Related Macular Degeneration and Its Progression
Recruiting
- Age Related Macular Degeneration
- +3 more
- N/A Observational study
-
East Melbourne, Victoria, AustraliaCentre for Eye Research Australia
Jul 20, 2022